Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design
Authors
D'Angelo, SBlay, JY
Chow, W
Demetri, G
Thistlethwaite, Fiona C
Wagner, M
Loeb, D
Attia, S
Razak, A
Haanen, J
Hasan, A
Billiard, J
Pearce, L
Wu, YH
Ji, R
Johnson, L
Srinath, C
Shalabi, A
Strauss, S
Thornton, K
Mackall, C
Tap, W
Van Tine, B
Affiliation
Memorial Sloan Kettering Cancer Center, New York, NYIssue Date
2019